APR July/August 2023 - 93

TUESDAY, OCTOBER 24
Begin the second full day of PharmSci 360
with a choice of symposia. " Advanced
Modelling and Predictive Approaches in Drug
Development, Manufacturing and Analysis "
includes presentations exploring AI and machine
learning, continuous manufacturing, deep
learning models, and digital twins. " Enabling
Excipients and Approaches for Advancing
Formulation and Delivery " examines new
approaches to formulation.
The symposia " Harnessing the Power of AI/ML
in Drug Development " promises to be a " can't
miss " session with a presentation diving into the
current regulatory environment.
Afternoon keynotes address twenty-first century
excipient taxonomy, long-acting injectable
formulations, and use of process modeling
and digital twins for monoclonal antibody
bioprocessing.
Don't miss the Speaker Spotlight from USP's
Catherine Sheehan! She provides information on
USP excipient standards.
End the day by attending a Hot Topic panel
on ICH M10.
WEDNESDAY, OCTOBER 25
On the final day of PharmSci 360, participate
once again in a selection of symposia. " Novel
Modalities and Cross-Modality Considerations
in Manufacturing and Analysis " explores
regulatory requirements for extractables and
leachables testing in combination products,
statistical methods, and submicron particles.
" The Bioanalytical Lab of the Future " examines
metabolomics, biomarkers, assays for cell and
gene therapies, and proteomics.
Fernando Muzzio, Ph.D., offers insights into the
future of advanced manufacturing in a Speaker
Spotlight.
Afternoon Keynotes address hot advancements
in science. U.S. FDA's Jason Rodriguez, Ph.D.,
highlights high-resolution analytical tools for
enhancing regulatory science. Another Keynote
looks at microfluidic technology as a drug
delivery technology.
After a busy threeand-a-half
days, Julie
DeMartino, Ph.D., closes
out PharmSci 360. She
is the founder and CEO
of AcheneRx, a pharma
consulting firm focusing
on drug discovery and
development of novel treatments for debilitating
and progressive diseases.
Before you leave, join us for the Closing
Reception from 5:30 pm to 6:30 pm and say
farewell to your colleagues and your new
industry connections.
In addition to these sessions, each full day includes career development resources,
Rapid Fire presentations and opportunities to visit poster presentations.
FOR MORE INFORMATION and
to access the full program, visit
www.aaps.org/pharmsci360.
http://www.aaps.org/pharmsci360
APR July/August 2023

Table of Contents for the Digital Edition of APR July/August 2023
